PubMed:32178765 / 2924-3070
Annnotations
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T20","span":{"begin":0,"end":146},"obj":"Sentence"},{"id":"T20","span":{"begin":0,"end":146},"obj":"Sentence"}],"text":"Guselkumab demonstrated a favourable benefit-risk profile and might be an effective treatment option for patients with active psoriatic arthritis."}
yaoziqian_800_3
{"project":"yaoziqian_800_3","denotations":[{"id":"T22","span":{"begin":0,"end":10},"obj":"CI"},{"id":"T23","span":{"begin":126,"end":145},"obj":"DP"}],"text":"Guselkumab demonstrated a favourable benefit-risk profile and might be an effective treatment option for patients with active psoriatic arthritis."}
Zierdiyeerkenaili_800_3
{"project":"Zierdiyeerkenaili_800_3","denotations":[{"id":"T3","span":{"begin":0,"end":10},"obj":"CI"},{"id":"T9","span":{"begin":126,"end":145},"obj":"DP"}],"text":"Guselkumab demonstrated a favourable benefit-risk profile and might be an effective treatment option for patients with active psoriatic arthritis."}